senate Bill S1753

Prohibits the substitution of opioid analgesic drugs for an opioid analgesic drug incorporating tamper resistance technology

download pdf

Sponsor

Co-Sponsors

Bill Status


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor
view actions

actions

  • 09 / Jan / 2013
    • REFERRED TO HEALTH
  • 28 / Feb / 2013
    • REPORTED AND COMMITTED TO FINANCE
  • 08 / Jan / 2014
    • REFERRED TO HEALTH

Summary

Prohibits the substitution of opioid analgesic drugs for an opioid analgesic drug incorporating tamper resistance technology; requires pharmacist to verify equivalence or obtain written consent of prescribing physician.

do you support this bill?

Bill Details

See Assembly Version of this Bill:
A877
Versions:
S1753
Legislative Cycle:
2013-2014
Current Committee:
Senate Health
Law Section:
Public Health Law
Laws Affected:
Add ยง3346, Pub Health L
Versions Introduced in 2011-2012 Legislative Cycle:
S6062, A7634

Votes

8
4
8
Aye
4
Nay
5
aye with reservations
0
absent
0
excused
0
abstained
show Health committee vote details

Sponsor Memo

BILL NUMBER:S1753

TITLE OF BILL:
An act
to amend the public health
law, in relation to prohibiting the substitution
of opioid analgesic drugs for an opioid analgesic drug incorporating
tamper resistance technology

PURPOSE OR GENERAL IDEA OF BILL: To ensure that every
opioid analgesic
drug is used for its proper purpose.

SUMMARY OF SPECIFIC PROVISIONS: Section 1 adds a new
section 3346 to
the Public health law to prohibit without physician over-ride the use
of non-tamper resistance opioid analgesic drugs and make definitions
of such.

Section 2 is the effective date of the bill.

JUSTIFICATION: Opioid use and abuse has increased
greatly in the
United States since the 1590's and continues to rise while the
benefits of these Products in treating and managing pain are widely
recognized, the potential for misuse and abuse of these products has
long been a concern of manufacturers, state and federal law
enforcement, healthcare providers, legislators, and regulators. Under
this proposal, when a physician prescribes an opioid analgesic drug
that incorporates a tamper resistance technology, no substitution or
interchange shall be permitted for that drug without the pharmacy,
(1) verifying that the substitute provides substantially similar
tamper resistance properties as determined by the State, or (2)
obtaining the prior, written consent of the prescribing physician.

PRIOR LEGISLATIVE HISTORY: S.6062 (2012)

FISCAL IMPLICATIONS: None

EFFECTIVE DATE: This act shall take effect immediately.

view bill text
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  1753

                       2013-2014 Regular Sessions

                            I N  S E N A T E

                               (PREFILED)

                             January 9, 2013
                               ___________

Introduced  by Sens. MARTINS, LAVALLE -- read twice and ordered printed,
  and when printed to be committed to the Committee on Health

AN ACT to amend the public health law, in relation  to  prohibiting  the
  substitution  of  opioid  analgesic drugs for an opioid analgesic drug
  incorporating tamper resistance technology

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  The  public health law is amended by adding a new section
3346 to read as follows:
  S 3346. CERTAIN OPIOID SUBSTITUTIONS PROHIBITED.   1. DEFINITIONS.  A.
"INTERCHANGE  OR  SUBSTITUTION  OF  AN  OPIOID ANALGESIC DRUG" MEANS THE
SUBSTITUTION OF ANY OPIOID ANALGESIC DRUG, BRAND  OR  GENERIC,  FOR  THE
OPIOID  ANALGESIC  DRUG  INCORPORATING  A  TAMPER-RESISTANCE  TECHNOLOGY
ORIGINALLY PRESCRIBED, IRRESPECTIVE OF WHETHER THE SUBSTITUTED  DRUG  IS
RATED  AS  PHARMACEUTICALLY  AND  THERAPEUTICALLY EQUIVALENT BY THE U.S.
FOOD AND DRUG ADMINISTRATION OR STATE BOARD OF PHARMACY OR  WHETHER  THE
OPIOID ANALGESIC DRUG WITH TAMPER-RESISTANCE TECHNOLOGY BEARS A LABELING
CLAIM WITH RESPECT TO REDUCTION OF TAMPERING, ABUSE OR ABUSE POTENTIAL.
  B.  "OPIOID  ANALGESIC DRUG" MEANS A DRUG IN THE OPIOID ANALGESIC DRUG
CLASS PRESCRIBED TO TREAT MODERATE TO SEVERE PAIN OR  OTHER  CONDITIONS,
WHETHER IN IMMEDIATE RELEASE OR EXTENDED RELEASE FORM AND WHETHER OR NOT
COMBINED  WITH  OTHER  DRUG  SUBSTANCES TO FORM A SINGLE TABLET OR OTHER
DOSAGE FORM.
  C. "OPIOID ANALGESIC DRUG INCORPORATING A TAMPER-RESISTANCE  TECHNOLO-
GY"  MEANS AN OPIOID ANALGESIC DRUG LISTED AS SUCH BY THE STATE BOARD OF
PHARMACY BASED UPON A SUBMISSION OF EVIDENCE BY THE DRUG MANUFACTURER OR
DISTRIBUTOR THAT THE DRUG: (I) INCORPORATES A TAMPER-RESISTANCE TECHNOL-
OGY; AND (II) HAS BEEN APPROVED BY THE U.S. FOOD AND DRUG ADMINISTRATION
PURSUANT TO AN APPLICATION THAT INCLUDES AT LEAST ONE HUMAN TAMPERING OR
ABUSE POTENTIAL STUDY OR A LABORATORY STUDY  COMPARING  THE  TAMPER-  OR

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD04583-01-3

S. 1753                             2

ABUSE-RESISTANCE  PROPERTIES OF THE DRUG TO ONE OR MORE OPIOID ANALGESIC
DRUGS THAT (A) HAVE BEEN APPROVED BY THE U.S.  FOOD  AND  DRUG  ADMINIS-
TRATION; AND (B) SERVE AS A POSITIVE CONTROL.
  D.  "PHARMACIST"  FOR PURPOSES OF THIS SECTION INCLUDES ANY PHARMACIST
DISPENSING DRUGS UNDER THE JURISDICTION OF THE STATE BOARD OF  PHARMACY,
INCLUDING  BUT  NOT  LIMITED  TO,  COMMUNITY PHARMACISTS, PHARMACISTS IN
HOSPITAL-BASED PHARMACIES WHEN FILLING PRESCRIPTIONS  FOR  INPATIENT  OR
OUTPATIENT  CARE,  AND  PHARMACISTS IN MAIL ORDER PHARMACIES LICENSED BY
THE STATE TO DISTRIBUTE IN THE STATE.
  2. LIST OF OPIOID ANALGESIC DRUGS  INCORPORATING  A  TAMPER-RESISTANCE
TECHNOLOGY.    THE STATE BOARD OF PHARMACY SHALL CREATE A LIST OF OPIOID
ANALGESIC DRUGS FOR WHICH INFORMATION HAS BEEN SUBMITTED CONSISTENT WITH
PARAGRAPH C OF SUBDIVISION ONE OF THIS SECTION. INCLUSION OF A  DRUG  ON
SUCH  LIST  SHALL  NOT  REQUIRE  THAT  A DRUG BEAR A LABELING CLAIM WITH
RESPECT TO REDUCTION OF TAMPERING, ABUSE OR ABUSE POTENTIAL AT THE  TIME
OF LISTING. SUCH LIST SHALL ALSO INCLUDE A DETERMINATION BY THE BOARD AS
TO  WHICH  LISTED OPIOID ANALGESIC DRUGS INCORPORATING TAMPER-RESISTANCE
TECHNOLOGIES PROVIDE SUBSTANTIALLY SIMILAR TAMPER-RESISTANCE PROPERTIES,
BASED SOLELY UPON STUDIES SUBMITTED BY THE DRUG MANUFACTURER  CONSISTENT
WITH PARAGRAPH C OF SUBDIVISION ONE OF THIS SECTION.
  3.  PROHIBITION. NOTWITHSTANDING THE PROVISIONS OF SECTION SIXTY-EIGHT
HUNDRED SIXTEEN-A OF THE EDUCATION LAW, NO PHARMACIST SHALL  INTERCHANGE
OR  SUBSTITUTE  AN  OPIOID  ANALGESIC  DRUG, BRAND OR GENERIC, OTHERWISE
ELIGIBLE FOR SUCH INTERCHANGE OR SUBSTITUTION UNDER SECTION  SIXTY-EIGHT
HUNDRED  SIXTEEN-A  OF  THE  EDUCATION  LAW FOR AN OPIOID ANALGESIC DRUG
INCORPORATING A TAMPER-RESISTANCE TECHNOLOGY THAT IS LISTED PURSUANT  TO
SUBDIVISION TWO OF THIS SECTION WITHOUT:
  A.    VERIFYING  THAT THE OPIOID ANALGESIC DRUG HAS BEEN LISTED BY THE
STATE BOARD OF PHARMACY:   UNDER SUBDIVISION  TWO  OF  THIS  SECTION  AS
PROVIDING  TAMPER-RESISTANCE  PROPERTIES  SUBSTANTIALLY  SIMILAR  TO THE
PRESCRIBED OPIOID ANALGESIC DRUG INCORPORATING A TAMPER-RESISTANCE TECH-
NOLOGY; OR
  B. OBTAINING WRITTEN, SIGNED CONSENT FROM  THE  PRESCRIBING  PHYSICIAN
FOR SUCH INTERCHANGE OR SUBSTITUTION.
  S 2. This act shall take effect immediately.

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.